P2.11A.08 Molecular and Immunological Features Associated with Long-Term Benefit in Metastatic NSCLC Patients Undergoing Immune Checkpoint Blockade
Rocha, P., Bach, R., Masfarre, L., Hernandez, S., Navarro-Gorro, N., Rossell, A., Villanueva, X., Giner, M., Sanchez, I., Galindo, M., del Rey-Vergara, R., Iñañez, A., Sanchéz-Espiridion, B., Lu, W., Acedo-Terrades, A., Berenguer-Molins, P., Sánchez-Font, A., Chalela, R., Curull, V., Taus, Á., Hardy-Werbin, M., Sausen, M., Georgiadis, A., White, J., Jackson, J.B., Moliner, L., Clavé, S., Bellosillo, B., Rovira, A., Wistuba, I., Solis Soto, L.M., Perera-Bel, J., Arriola, E.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article